Shin-ichiro Ashida

754 total citations
27 papers, 606 citations indexed

About

Shin-ichiro Ashida is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Shin-ichiro Ashida has authored 27 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Shin-ichiro Ashida's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Platelet Disorders and Treatments (4 papers). Shin-ichiro Ashida is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (6 papers) and Platelet Disorders and Treatments (4 papers). Shin-ichiro Ashida collaborates with scholars based in Japan. Shin-ichiro Ashida's co-authors include Yasushi Abiko, Hitoshi Yamaguchi, Shigeo Watabe, Hidemasa Ogawa, Masao Shimizu, Fumiyoshi Ishikawa, Mitsuru Murata, Toshihiro Uchida, Kenji Soejima and Yasuo Ikeda and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Shin-ichiro Ashida

26 papers receiving 553 citations

Peers

Shin-ichiro Ashida

CCM

HEMAT

PHARM

IMMUN

Roma A. Armstrong United Kingdom

David C. B. Mills United States

Robert B. Wallis United Kingdom

Adriana Menichelli Italy

Waldemar Radziszewski United States

William M. Selig United States

Serge Simonet France

Irena Duka United States

A. Ocetkiewicz Poland

Jan‐Arne Björkman Sweden

Roma A. Armstrong United Kingdom

Shin-ichiro Ashida

152 ×0.8

CCM

45 ×0.4

HEMAT

201 ×1.7

272 ×2.4

PHARM

86 ×1.0

IMMUN

Citations per year, relative to Shin-ichiro Ashida Shin-ichiro Ashida (= 1×) peers Roma A. Armstrong

Countries citing papers authored by Shin-ichiro Ashida

Since Specialization

Citations

This map shows the geographic impact of Shin-ichiro Ashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin-ichiro Ashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin-ichiro Ashida more than expected).

Fields of papers citing papers by Shin-ichiro Ashida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin-ichiro Ashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin-ichiro Ashida. The network helps show where Shin-ichiro Ashida may publish in the future.

Co-authorship network of co-authors of Shin-ichiro Ashida

This figure shows the co-authorship network connecting the top 25 collaborators of Shin-ichiro Ashida. A scholar is included among the top collaborators of Shin-ichiro Ashida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin-ichiro Ashida. Shin-ichiro Ashida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murata, Mitsuru, Yumiko Matsubara, Toshihiro Uchida, et al.. (2003). Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. Biochemical and Biophysical Research Communications. 313(1). 212–216. 84 indexed citations

Watabe, Shigeo, Hitoshi Yamaguchi, & Shin-ichiro Ashida. (1993). DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex. European Journal of Pharmacology. 238(2-3). 303–309. 44 indexed citations

Moriyama, Sachiko, et al.. (1993). Effects of perindopril on tissue angiotensin- converting enzyme activity in rats with myocardial infarction.. The Japanese Journal of Pharmacology. 61. 211–211. 1 indexed citations

Kunitada, Satoshi, et al.. (1992). A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy. European Journal of Pharmacology. 210(2). 163–172. 15 indexed citations

Kunitada, Satoshi, et al.. (1991). A thromboxane A2 synthase inhibitor, DP-1904, prevents rat renal injury. European Journal of Pharmacology. 193(3). 321–327. 14 indexed citations

Kanda, Akira, et al.. (1990). Uricosuric and Diuretic Activities of DR-3438 in Dogs and Rabbits. The Japanese Journal of Pharmacology. 54(3). 307–314. 1 indexed citations

Tanaka, Satoru, Shin-ichiro Ashida, & Akira Akashi. (1990). Effects of Antihypertensive Drugs on Experimental Cerebral Ischemia in Spontaneously Hypertensive Rats. The Japanese Journal of Pharmacology. 53(4). 502–505. 1 indexed citations

Ashida, Shin-ichiro, et al.. (1990). Prevention of coronary vasospasm by a novel Ca++ antagonist, SD-3211 (Sesamodii) in rats. The Japanese Journal of Pharmacology. 52. 213–213. 2 indexed citations

Terashi, Akiro, et al.. (1990). Role of platelets as a factor aggravating cerebral ischemia.. Japanese Circulation Journal. 54(12). 1511–1516. 4 indexed citations

10.

Watanabe, Yoshifumi, et al.. (1989). Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indane derivatives. Journal of Medicinal Chemistry. 32(6). 1326–1334. 27 indexed citations

11.

Watanabe, Yoshifumi, et al.. (1988). Thromboxane A2 synthetase inhibitors. I. Syntheses and activities of various N-heteroaromatic derivatives.. Chemical and Pharmaceutical Bulletin. 36(8). 2968–2976. 2 indexed citations

12.

Ishikawa, Fumiyoshi, et al.. (1985). Cyclic guanidines. 17. Novel (N-substituted amino)imidazo[2,1-b]quinazolin-2-ones: water-soluble platelet aggregation inhibitors. Journal of Medicinal Chemistry. 28(10). 1387–1393. 18 indexed citations

13.

Ashida, Shin-ichiro, et al.. (1983). Hemorheological effect of ticlopidine in the rat. Thrombosis Research. 31(4). 549–556. 11 indexed citations

14.

Ishikawa, Fumiyoshi, et al.. (1981). Cyclic guanidines. 14. Imidazo[1,2-a]thienopyrimidin-2-one derivatives as blood platelet aggregation inhibitors. Journal of Medicinal Chemistry. 24(4). 376–382. 23 indexed citations

15.

Ashida, Shin-ichiro & Yasushi Abiko. (1979). Mode of Action of Ticlopidine in Inhibition of Platelet Aggregation in the Rat. Thrombosis and Haemostasis. 41(2). 436–449. 71 indexed citations

16.

Tomikawa, Munehiro, et al.. (1978). Anti-thrombotic action of ticlopidine, a new platelet aggregation inhibitor. Thrombosis Research. 12(6). 1157–1164. 29 indexed citations

17.

Ashida, Shin-ichiro & Yasushi Abiko. (1978). Inhibition of Platelet Aggregation by a New Agent, Ticlopidine. Thrombosis and Haemostasis. 40(2). 542–550. 76 indexed citations

18.

Ashida, Shin-ichiro & Yasushi Abiko. (1978). Effect of ticlopidine and acetylsalicylic acid on generation of prostaglandin I2-like substance in rat arterial tissue. Thrombosis Research. 13(5). 901–908. 29 indexed citations

19.

Abiko, Yasushi, Shin-ichiro Ashida, & Masao Shimizu. (1972). Purification and properties of d-pantothenate kinase from rat liver. Biochimica et Biophysica Acta (BBA) - Enzymology. 268(2). 364–372. 29 indexed citations

20.

Kakemi, Kiichiro, Hitoshi Sezaki, Katsuhiko Okumura, & Shin-ichiro Ashida. (1969). Absorption and Excretion of Drugs. XXXIX. The Absorption of Isonicotinic Acid Derivatives from the Skeletal Muscle of the Rats. Chemical and Pharmaceutical Bulletin. 17(7). 1332–1338. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact